HRTX News and Press, Heron Therapeutics Inc. From 05/11/23

Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2023 and Highlights Recent Corporate Updates PR Newswire · Net Product Sales for First Quarter of 2023 Grew 26% to $29.6 million , Compared to First Quarter Net Product Sales in 2022 ...

2023-05-10 17:35:58 ET Heron Therapeutics ( NASDAQ: HRTX ) is scheduled to announce Q1 earnings results on Thursday, May 11th, after market close. The consensus EPS Estimate is -$0.20 and the consensus Revenue Estimate is $29.69M (+26.6% Y/Y). Over the last 1 year, HRT...

Heron Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023 PR Newswire SAN DIEGO , May 4, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of pat...

2023-04-26 03:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-04-21 15:11:46 ET Summary Shares of Heron surged this month as CEO Quart was replaced by Craig Collard. The company also made commercial leadership changes and all of this was driven by the recent cooperation agreement with Rubric Capital and Velan Capital. However, leade...

Heron Therapeutics Announces Commercial Leadership Changes PR Newswire SAN DIEGO , April 20, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron"), a commercial-stage biotechnology company focused on improving the lives of patients by developing ...

Heron Therapeutics Announces Presentation at 22nd Annual Needham Virtual Healthcare Conference PR Newswire SAN DIEGO , April 17, 2023 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives ...

2023-04-16 11:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-04-06 20:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-04-06 15:42:00 ET Shares of Heron Therapeutics (NASDAQ: HRTX) stormed higher by 47% over the first 3 1/2 days of trading this week, according to data provided by S&P Global Market Intelligence . The big gain came in response to the appointment of Craig Collard as Ch...